Morpholine → Cyclopropyl-(2,4-dichloro-6-morpholin-4-yl-pyrimidin-5-yloxy)-acetic acid methyl ester

HRID 528473Notes

Reaction equation

HRID 528473 reaction equation
[CH3:1][O:2][C:3](=[O:18])[CH:4]([CH:15]1[CH2:17][CH2:16]1)[O:5][C:6]1[C:7](Cl)=[N:8][C:9]([Cl:13])=[N:10][C:11]=1[Cl:12].C(N(CC)CC)C.[NH:26]1[CH2:31][CH2:30][O:29][CH2:28][CH2:27]1>>[CH3:1][O:2][C:3](=[O:18])[CH:4]([CH:15]1[CH2:17][CH2:16]1)[O:5][C:6]1[C:11]([Cl:12])=[N:10][C:9]([Cl:13])=[N:8][C:7]=1[N:26]1[CH2:31][CH2:30][O:29][CH2:28][CH2:27]1

Participants

4

Procedure

To a suspension of cyclopropyl-(2,4,6-trichloro-pyrimidin-5-yloxy)-acetic acid methyl ester (224 mg, 0.72 mmol) in IMS (4 mL) was added triethylamine (150 μL, 1.08 mmol) followed by morpholine (63 μL, 0.72 mmol). The yellow solution was stirred for 2.5 hours at RT before being concentrated in vacuo. The resultant residue was purified by column chromatography (SiO2, gradient 0-20% ethyl acetate in cyclohexane) affording Cyclopropyl-(2,4-dichloro-6-morpholin-4-yl-pyrimidin-5-yloxy)-acetic acid methyl ester as a colourless gum (233 mg, 89%). 1H NMR (CDCl3): δ 3.99 (1H, d, J=9.54 Hz), 4.03-3.83 (4H, m), 3.80-3.75 (4H, m), 3.78 (3H, s), 1.32-1.21 (1H, m), 0.70-0.57 (2H, m), 0.52-0.45 (1H, m), 0.33-0.26 (1H, m).

Workup

  1. concentrationbefore being concentrated in vacuo
  2. customThe resultant residue was purified by column chromatography (SiO2, gradient 0-20% ethyl acetate in cyclohexane)

Sources & evidence

ORD record
ord-2e3801d9866240c5a7a1c522f4271719
Source dataset
uspto-grants-2016_05
Patent number
US09346817B2

Reaction notes

Loading…